Search

Search Constraints

You searched for: Author/Creator Kwong, Peter D.

Search Results

1. A matrix of structure-based designs yields improved VRC01-class antibodies for HIV-1 therapy and prevention. Issue 1 (1st January 2021)

2. A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses. Issue 1 (31st December 2022)

3. A non-affinity purification process for GMP production of prefusion-closed HIV-1 envelope trimers from clades A and C for clinical evaluation. Issue 25 (8th June 2021)

4. Antibodies as drugs—a Keystone Symposia report. Issue 1 (16th November 2022)

5. Antibody screening at reduced pH enables preferential selection of potently neutralizing antibodies targeting SARS‐CoV‐2. Issue 12 (4th October 2021)

7. Antibodyomics: bioinformatics technologies for understanding B‐cell immunity to HIV‐1. Issue 1 (January 2017)

8. Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency. Issue 1 (31st December 2023)

10. Development of Neutralization Breadth against Diverse HIV‐1 by Increasing Ab–Ag Interface on V2. Issue 15 (23rd March 2022)